New Drug CS18 Helps Cancer Cells Vulnerable to Treatment
Researchers at Baylor College of Medicine created an experimental drug that weakens multiple cancer survival mechanisms at once, potentially solving one of medicine's toughest challenges. Early results show it helps resistant tumors respond to treatment again.
